Results 81 to 90 of about 118,119 (154)

Explainable machine learning for predicting recurrence-free survival in endometrial carcinosarcoma patients

Frontiers in Artificial Intelligence
ObjectivesEndometrial carcinosarcoma is a rare, aggressive high-grade endometrial cancer, accounting for about 5% of all uterine cancers and 15% of deaths from uterine cancers. The treatment can be complex, and the prognosis is poor.
Samantha Bove, Francesca Arezzo, Francesca Arezzo, Gennaro Cormio, Gennaro Cormio, Erica Silvestris, Alessia Cafforio, Maria Colomba Comes, Annarita Fanizzi, Giuseppe Accogli, Gerardo Cazzato, Giorgio De Nunzio, Giorgio De Nunzio, Brigida Maiorano, Emanuele Naglieri, Andrea Lupo, Elsa Vitale, Vera Loizzi, Vera Loizzi, Raffaella Massafra   +19 more
doaj   +1 more source

Case report: Carcinosarcoma of uterus in nulliparous women

Frontiers in Oncology
BackgroundUterine carcinosarcoma (UCS), or malignant mixed Müllerian tumor, is a cancer that include both carcinomatous and sarcomatous components, resembling endometrial carcinoma.
Feiyue Sun, Xuelei Li, Luyao Kang, Yiran Wang, Hongyu Li, Hai Zhu   +5 more
doaj   +1 more source

Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis

, 2009
A 58-year-old woman underwent a curative total abdominal hysterectomy with bilateral salpingo-oophorectomy for a uterine carcinosarcoma. Fifteen months later, PET and CT scan revealed three pulmonary nodules and multiple lymphadenopathy. An atypical lung
Rindi, Guido, G. Rindi, G. Fellegara, G. Pruneri, E. Froio, P. Caruana, T. D'Adda, E. Martella, A. Pesci   +8 more
core   +1 more source

Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy [PDF]

, 2008
Introduction: Asoprisnil, a novel orally active selective progesterone receptor modulator, is being studied for the management of symptomatic uterine leiomyomata. The exact mechanism of action is not yet discerned.
Williams, A.R.W., Chwalisz, K., Hapangama, D., Critchley, Hilary O.D., Wilkens, Julia, Walker, Jane, Lawrence, A.C., Williams, Alistair R.W., Lumsden, M.A., Lawrence, Alexandra C., Ingamells, S., Chwalisz, Kristof, Hapangama, Dharani, Critchley, H.O.D., Han, Cong, Ingamells, Susan, Wilkens, J., Cameron, I.T., Cameron, Iain T., Lumsden, Mary Ann, Han, C., Walker, J.   +21 more
core   +1 more source

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas

Balkan Medical Journal, 2016
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcomas have not yet been clearly defined. Although carcinosarcomas are more aggressive than pure epithelial tumours, they are treated similarly.
İrfan Cicin, Tahsin Özatlı, Esma Türkmen, Türkan Özturk, Melike Özçelik, Devrim Çabuk, Ayşe Gökdurnalı, Özlem Balvan, Yaşar Yıldız, Metin Şeker, Nuriye Özdemir, Burcu Yapar, Özgür Tanrıverdi, Yusuf Günaydin, Serkan Menekşe, Berna Öksüzoğlu, Asude Aksoy, Bülent Erdoğan, M. Bekir Hacıoglu, Erkan Arpaci, Alper Sevinç, Mehmet Atilla Uysal, Sinem İliaz   +22 more
doaj   +1 more source

Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma

Background Uterine carcinosarcomas are uncommon with about 35% not confined to the uterus at diagnosis. The survival of patients with advanced uterine carcinosarcoma is poor with pattern of failure indicating greater likelihood of upper abdominal and ...
Bryant A; Kucukmetin A; Galaal K; Godfrey K; Naik R
core   +5 more sources

Surgical staging identifies occult metastases in over 50% of uterine-confined carcinosarcoma

Gynecologic Oncology Reports
Objective: To evaluate and define the proportion of clinically stage I Uterine Carcinosarcoma (UCS) patients who are upstaged to FIGO stages II-IVB following primary surgery based on final pathology.
William Vintzileos, Hannah Beer, David Miller, Jayanthi Lea   +3 more
doaj   +1 more source

Matched-pair Analysis for Survival Endpoints Between Women With Early-stage Uterine Carcinosarcoma and Uterine Serous Carcinoma

, 2021
OBJECTIVE: The objective of this study was to compare survival endpoints between women with uterine carcinosarcoma and those with uterine serous carcinoma utilizing matching analysis.
Hijaz, Miriana Y, Zhu, Simeng, Elshaikh, Mohamed A, Burmeister, Charlotte, Yahya, Jehan B   +4 more
core   +1 more source

A case of uterine carcinosarcoma

, 2008
Uterine carcinosarcoma is a highly aggressive neoplasm with tendency to early recurrence and/or metastasis. The neoplasia has both epithelial and stromal malignant components.
NARDECCHIA G, PICCHIO M, STAGNITTI, Franco, CECI F, NICODEMI S, BRIGANTI M, SPAZIANI, Erasmo, SARDELLA B, DI FILIPPO, Annalisa Romina, CENSI F, DE ANGELIS F, PETROZZA, Vincenzo, CIPRIANI B.   +12 more
core  

The outcome of patients with uterine carcinosarcoma

, 2018
A research report for the fulfillment of the requirement by the MSc (Research) degree of the University of Witwatersrand, 2018Objectives. The study aimed to determine the outcome of women with uterine carcinosarcoma and treated with surgery alone ...
Mbodi, Langanani
core